Cell Genesys News
Most Popular Cell Genesys Story
BioSante, Cell Genesys merger will provide cash for Phase III
BioSante Pharmaceuticals says that its planned merger with Cell Genesys will bring in between $20 million and $25 million, which can fund its development program for a gel to treat female sexual... Read more...
Latest Headlines
- June 30, 2009
- June 23, 2009
- December 3, 2008
- October 16, 2008
- August 28, 2008
- August 27, 2008
- April 10, 2008
- April 10, 2008
- April 1, 2008
- January 9, 2007
- October 31, 2006
- July 31, 2006
- March 28, 2006
- December 11, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
